Which of the following could be a consequence of inadequate traceability?

Prepare for the Certified Pharmaceutical GMP Professional Exam. Use flashcards and multiple-choice questions, each with detailed hints and explanations. Ace your certification!

Inadequate traceability refers to the inability to track the history, application, or location of products through various stages of production and distribution. This lack of proper tracking can lead to a number of issues within the pharmaceutical industry, with one significant consequence being the potential recall of products.

When traceability is compromised, it becomes challenging to identify the specific batches of products that may be affected by quality issues, such as contamination or defects. If a problem is detected after distribution, the inability to trace the affected products back to their source makes it difficult to manage a targeted recall effectively. This can result in a broader recall that disrupts the supply chain, affects patient safety, and can lead to significant financial losses and damage to the company’s reputation.

The other choices such as improved customer satisfaction, enhanced market position, and better staff performance do not directly correlate with the consequences of inadequate traceability. In fact, inadequate traceability is more likely to diminish customer satisfaction and negatively affect market position and staff performance due to the repercussions of product recalls and the resulting flaws in operational integrity.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy